Why health care stocks are still undervalued: Podcast
Uri Landesman, head of global growth at ING Investment Management Americas, talks about the immediate and longer-term impact of health care reform on health care sector stocks.
Uri Landesman, head of global growth at ING Investment Management Americas, talks about the immediate and longer-term impact of health care reform on health care sector stocks.
(Click here to download.)
Mr. Landesman, who manages $1.7 billion in pension assets, believes pharmaceutical companies are well positioned and that the overall sector is undervalued relative to the overall market.
Learn more about reprints and licensing for this article.